Comparative pharmacokinetics of topical tacrolimus cream 0.03% with cream 0.01% and ointment 0.03% in adults and with ointment 0.03% in pediatric patients with atopic dermatitis

被引：0
|
作者：
Jones, T
Apseloff, G
Carter, E
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Columbia Univ, New York, NY USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P68 / P68
页数：1
相关论文
共 50 条
  • [1] Pimecrolimus cream 1% demonstrates better local tolerability than tacrolimus ointment 0.03% in pediatric patients with atopic dermatitis
    Kempers, S
    Jarrat, M
    Pariser, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P3 - P3
  • [2] Efficacy of 0.03% tacrolimus ointment in patients with atopic dermatitis of the head and neck
    Suhr, KB
    Kim, YS
    Yoon, JS
    Lee, EJ
    Kye, KC
    Lee, JH
    Park, JK
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (05) : 1265 - 1265
  • [3] Efficacy and safety of 0.01% and 0.03% tacrolimus cream versus cream vehicle in mild to moderate atopic dermatitis
    Abramovits, W
    Matheson, R
    Stewart, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P69 - P69
  • [4] The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis
    Reitamo, Sakari
    Mandelin, Johanna
    Rubins, Andris
    Remitz, Anita
    Maekelae, Mika
    Cirule, Kristine
    Rubins, Silvestrs
    Zigure, Sanita
    Ho, Vincent
    Dickinson, James
    Undre, Nasrullah
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (04) : 348 - 355
  • [5] Treatment of Refractory Atopic Blepharoconjunctivitis with Topical Tacrolimus 0.03% Dermatologic Ointment
    Sakarya, Yasar
    Sakarya, Rabia
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (01) : 94 - 96
  • [6] A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis
    Kempers, S
    Boguniewicz, M
    Carter, E
    Jarratt, M
    Pariser, D
    Stewart, D
    Stiller, M
    Tschen, E
    Chon, K
    Wisseh, S
    Abrams, B
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) : 515 - 525
  • [7] Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis
    Chapman, MS
    Schachner, LA
    Breneman, D
    Boguniewicz, M
    Gold, MH
    Shull, T
    Linowski, GJ
    Jaracz, E
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) : S177 - S185
  • [8] Tacrolimus ointment 0.03 is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric and adult patients
    Chapman, MS
    Schachner, L
    Breneman, D
    Boguniewicz, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P3 - P3
  • [9] TREATMENT OF PEDIATRIC PITYRIASIS ALBA PATIENTS WITH 0.03% TACROLIMUS OINTMENT
    Buongermini, A.
    Mena, C.
    Valencia, A.
    [J]. PEDIATRIC RESEARCH, 2010, 67 (04) : 447 - 447
  • [10] Vaccination response is equivalent in children with atopic dermatitis treated with 0.03% tacrolimus ointment or a hydrocortisone ointment regimen
    Cranswick, N
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB84 - AB84
12345